Boston Scientific Corporation (BSX) vs Elevance Health Inc. (ELV)
BSX leads on 9 of 16 compared metrics, though ELV is the cheaper stock.
A side-by-side comparison of Boston Scientific Corporation and Elevance Health Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 17, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
BSX
Boston Scientific Corporation
$46.92Healthcare
ELV
Elevance Health Inc.
$401.89Healthcare
Total return — BSX vs ELV
growth of $100 · last 25yBSX +312.3%ELV +1854.3%ELV compounded faster
BSX ELV
BSX vs ELV: by the numbers
- •ELV is the larger company ($86.74B vs $69.74B market cap).
- •ELV trades at the lower earnings multiple (17.09 vs 19.71 P/E).
- •BSX converts more revenue to profit (17.24% vs 2.62% net margin).
- •BSX grew revenue faster over the past five years (15.29% vs 9.97% CAGR).
- •ELV pays a dividend (1.71% yield) while BSX does not currently pay one.
Which is better, BSX or ELV?
Metric tally: BSX 9 · ELV 7It depends on what you're optimizing for:
ValueELV(lower P/E)
GrowthBSX(faster 5Y revenue CAGR)
QualityBSX(higher ROIC)
Metrics side by side
Valuation
| Metric | BSX | ELV |
|---|---|---|
| P/E ratio | 19.71 | 17.09● |
| Forward P/E | 12.60● | 13.75 |
| P/S ratio | 3.40 | 0.44● |
| P/B ratio | 2.71 | 2.02● |
| PEG ratio | 0.88● | 2.56 |
| EV / EBITDA | 14.07 | 12.42● |
| FCF yield | 4.91% | 7.28%● |
Profitability
| Metric | BSX | ELV |
|---|---|---|
| Gross margin | 70.41%● | 23.16% |
| Operating margin | 20.12%● | 3.81% |
| Net margin | 17.24%● | 2.62% |
| ROE | 13.74%● | 11.94% |
| ROIC | 8.78%● | 6.65% |
Dividends
| Metric | BSX | ELV |
|---|---|---|
| Dividend yield | — | 1.71% |
| Payout ratio | — | 27.24% |
Growth (annualized)
| Metric | BSX | ELV |
|---|---|---|
| Revenue CAGR (5Y) | 15.29%● | 9.97% |
| EPS CAGR (5Y) | -8.67% | 6.67%● |
| FCF CAGR (5Y) | 19.89%● | -7.76% |
| Total return CAGR (5Y) | 1.86% | 2.56%● |
Frequently asked
- Which is better, BSX or ELV?
- It depends on your goal. value: ELV (lower P/E); growth: BSX (faster 5Y revenue CAGR); quality: BSX (higher ROIC). Across all compared metrics, BSX leads 9 to 7.
- Is BSX or ELV cheaper?
- On trailing earnings, ELV is cheaper: BSX trades at a 19.71 P/E and ELV at 17.09.
- Which has grown faster, BSX or ELV?
- Over the past five years, BSX grew revenue faster — BSX at a 15.29% CAGR versus ELV at 9.97%.
- Does BSX or ELV pay a bigger dividend?
- ELV pays a dividend (1.71% yield) while BSX does not currently pay one.
- Is BSX or ELV more profitable?
- BSX runs the higher net margin — BSX at 17.24% versus ELV at 2.62%.
- Which has been the better investment, BSX or ELV?
- Over the past 10-year, ELV delivered the higher annualized total return — BSX at 7.47% versus ELV at 13.25%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Boston Scientific P/E ratioElevance Health P/E ratioBoston Scientific dividend yieldElevance Health dividend yieldBoston Scientific ROEElevance Health ROEBoston Scientific operating marginElevance Health operating marginBoston Scientific revenue growthElevance Health revenue growthBoston Scientific free cash flowElevance Health free cash flow
Boston Scientific & Elevance Health appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 17, 2026.